Human umbilical cord blood cells and diabetes mellitus: Recent advances

Current Stem Cell Research and Therapy

Volumn 10, Issue 3, 2015, Pages 266-270

  Reddi, Alluru S ^a   Kothari, Neil ^a   Kuppasani, Kishore ^a   Ende, Norman ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Clinical trials; Diabetes mellitus; Differentiation; Human umbilical cord blood; Stem cell educator therapy; Stem cells; cells

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; C PEPTIDE; DOCOSAHEXAENOIC ACID; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; HEMOGLOBIN A1C; INSULIN; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD GLUCOSE MONITORING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; FOOT ULCER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; KIDNEY DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR NERVE CONDUCTION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL TRANSPLANTATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UMBILICAL CORD BLOOD; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING; CYTOLOGY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FETUS BLOOD; TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FETAL BLOOD; HUMANS;

EID: 84928951719     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X10666141212122421     Document Type: Article

References (49)

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2013; 103: 137-49.
2. Reddi AS, Kuppasani K, Ende N. Human umbilical cord blood as an emerging stem cell therapy for diabetes mellitus. Curr Stem Cell Res Ther 2010; 5: 356-61.
3. Koblas T, Harman SM, Saudek F. The application of umbilical cord blood cells in the treatment of diabetes mellitus. Rev Diabet Stud 2005; 2: 228-34.
4. Harris DT, Rogers I. Umbilical cord blood: A unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2007; 2: 301-9.
5. Bieback K, Kluter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2007; 2: 310-23.
6. Haylock DN, Nilsson SK. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther 2007; 2: 324-35.
7. Kogler G, Sensken S, Airey JA, et al.A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123-35.
8. Zhao Y, Wang H, Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res 2006; 312: 2454-64.
9. Murohara T. Therapeutic vasculogenesis using human cord bloodderived endothelial progenitors. Trends Cardiovasc Med 2001; 11: 303-7.
10. Denner L, Bodenburg Y, Zhao JG, et al.Directed engineering of umbilical cord blood stem cells to produce c-peptide and insulin. Cell Prolif 2007; 40: 367-80.
11. Parekh VS, Joglekar MV, Hardikar AA. Differentiation of human umbilical cord blood-derived mononuclear cells to endocrine pancreatic lineage. Differentiation 2009; 78: 232-40.
12. Prabakar KR, Dominguez-Bendala J, Molano RD, et al.Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant 2012; 21: 1321-39.
13. a] Zhang Y, Bandala-Sanchez E, Harrison LC. Revisiting regulatory T cells in type 1 diabetes. Curr Opin Diabetes Obes 2012, 19: 271-8.
14. Ende N, Chen R, Mack R. Nod/ltj type 1 diabetes in mice and the effect of stem cells (Berashis) derived from human umbilical cord blood. J Med 2002; 33: 181-7.
15. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004; 325: 665-9.
16. Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 2004; 321: 168-71.
17. Zhang F-T, Wan H-J, Ye J, et al.Therapeutic effect of human umbilical cord blood cells on diabetic mice. Cell Research 2008; 18: s48.
18. Hasein MA, Attia FM, Awad MM, Abdelaal HA, Elbarabary M. Effect of human umbilical cord blood cd34+ progenitor cells transplantation in diabetic mice International Journal of Diabetes in Developing Countries 2011; 31: 113-7.
19. Tsai PJ, Wang HS, Shyr YM, et al.Transplantation of insulinproducing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats. J Biomed Sci 2012; 19: 47.
20. El-Mesallamy HO, Diab MR, Hamdy NM, Dardir SM. Cell-based regenerative strategies for treatment of diabetic skin wounds, a comparative study between human umbilical cord bloodmononuclear cells and calves' blood haemodialysate. PLoS One 2014; 9: e89853.
21. Haller MJ, Viener H-L, Brusko T, et al.Insulin requirements, hba1c, and stimulated c-peptide following autologous umbilical cord blood transfusion in children with t1d. Diabetes 2007; 56; Supplement 1: pA82.
22. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008; 36: 710-5.
23. Haller MJ, Wasserfall CH, McGrail KM, et al.Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 2009; 32: 2041-6.
24. Haller MJ, Wasserfall CH, Hulme MA, et al.Autologous umbilical cord blood infusion followed by oral docosahexaenoic acid and vitamin d supplementation for c-peptide preservation in children with type 1 diabetes. Biol Blood Marrow Transplant 2013; 19: 1126-9.
25. Zhao Y, Jiang Z, Zhao T, et al.Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med 2012; 10: 3.
26. Zhao Y, Jiang Z, Zhao T, et al.Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (cb-scs) in stem cell educator therapy: Phase i/ii clinical trial. BMC Med 2013; 11: 160.
27. Li XY, Zheng ZH, Guo J, et al.Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: Response and correction of immunological anomalies. Curr Pharm Des 2013; 19: 4893-9.
28. Tong Q, Duan L, Xu Z, et al.Improved insulin secretion following intrapancreatic ucb transplantation in patients with t2dm. J Clin Endocrinol Metab 2013; 98: E1501-504.
29. Park JH, Hwang I, Hwang SH, Han H, Ha H. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract 2012; 98: 465-73.
30. Park JH, Park J, Hwang SH, Han H, Ha H. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury. Transplant Proc 2012; 44: 1123-6.
31. Bhattacharya N. Placental umbilical cord blood transfusion: A new method of treatment of patients with diabetes and microalbuminuria in the background of anemia. Clin Exp Obstet Gynecol 2006; 33: 164-8.
32. Naruse K, Hamada Y, Nakashima E, et al.Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005; 54: 1823-8.
33. Kang KS, Kim SW, Oh YH, et al.A 37-year-old spinal cordinjured female patient, transplanted of multipotent stem cells from human uc blood, with improved sensory perception and mobility, both functionally and morphologically: A case study. Cytotherapy 2005; 7: 368-73.
34. Park DH, Eve DJ, Chung YG, Sanberg PR. Regenerative medicine for neurological disorders. ScientificWorldJournal 2010; 10: 470-89.
35. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG. A review of gene and stem cell therapy in cutaneous wound healing. Burns 2009; 35: 171-80.
36. Valbonesi M, Giannini G, Migliori F, Dalla Costa R, Dejana AM. Cord blood (cb) stem cells for wound repair. Preliminary report of 2 cases. Transfus Apher Sci 2004; 30: 153-6.
37. Elsharawy MA, Naim M, Greish S. Human cd34+ stem cells promote healing of diabetic foot ulcers in rats. Interact Cardiovasc Thorac Surg 2012; 14: 288-93.
38. Jiang XY, Lu DB, Chen B. Progress in stem cell therapy for the diabetic foot. Diabetes Res Clin Pract 2012; 97: 43-50.
39. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. Cd34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003; 40: 368-77.
40. Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 2012; 96: 1-9.
41. Ende N. The Berashis cell: A review-is it similar to the embryonic stem cell? J Med 2000; 31: 113-30.
42. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: State of the art. Int J Clin Exp Med 2010; 3: 248-69.
43. Reddi AS, Ende N. The use of human umbilical cord blood for wound healing, burns, and brain injury in combat zones. Mil Med 2011; 176: 361-3.
44. Mayer E, Bannert C, Gruber S, et al.Cord blood derived cd4+ cd25(high) t cells become functional regulatory t cells upon antigen encounter. PLoS One 2012; 7: e29355.
45. Wang HS, Shyu JE, Hsu HC, et al.Transplantation of insulinproducing cells derived from umbilical cord blood stromal mesenchymal stem cells to treat NOD mice. Cell Transplant 2011; 20: 455-66.
46. Boroujeni ZN, Aleyasin A. Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo. Biotechnol Appll Biochem 2014; 61: 82-92.
47. Ende N, Lu S, Alcid MG, Chen R, Mack R. Pooled umbilical cord blood as a possible universal donor for marrow reconstitution and use in nuclear accidents. Life Sci 2001; 69: 1531-9.
48. Ende N, Lu S, Mack R, Ponzio NM. The feasibility of using blood bank-stored (4 degrees c) cord blood, unmatched for hla for marrow transplantation. Am J Clin Pathol 1999; 111: 773-81.
49. Han MX, Craig ME. Research using autologous cord blood – time for a policy change. Med J Aust 2013; 199: 288-99.